Mapping metastases in sentinel lymph nodes of breast cancer

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Localization of metastases within the sentinel lymph nodes (SLNs) of breast cancer has not been studied. Forty SLNs from 36 patients with operable primary breast cancers were identified by means of lymphatic mapping with patent blue dye. The junction between the patent blue-stained lymphatic vessel draining the tumor and the SLN was labeled with alcian blue. Metastases within the serially sectioned SLNs were assigned to the alcian blue-labeled side, to the opposite side of the virtually halved nodes, or both. Eight SLNs were negative for metastasis. Eleven SLNs had metastases only in the blue half only 4 cases had larger metastases in the nonblue half. Metastases are more likely to be located in the vicinity of the inflow junction of the identifiable lymphatic draining the tumor and the SLN. This should be considered when SLNs are examined, especially when they are halved for different studies.

Original languageEnglish
Pages (from-to)351-354
Number of pages4
JournalAmerican Journal of Clinical Pathology
Volume113
Issue number3
Publication statusPublished - 2000

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Alcian Blue
Lymphatic Vessel Tumors
Sentinel Lymph Node
Coloring Agents
Neoplasms

Keywords

  • Axillary sentinel node
  • Breast cancer
  • Histology
  • Lymphatic mapping
  • PCR
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Mapping metastases in sentinel lymph nodes of breast cancer. / Cserni, G.

In: American Journal of Clinical Pathology, Vol. 113, No. 3, 2000, p. 351-354.

Research output: Contribution to journalArticle

@article{0cea8d85396d4fd28567532ec0e563bc,
title = "Mapping metastases in sentinel lymph nodes of breast cancer",
abstract = "Localization of metastases within the sentinel lymph nodes (SLNs) of breast cancer has not been studied. Forty SLNs from 36 patients with operable primary breast cancers were identified by means of lymphatic mapping with patent blue dye. The junction between the patent blue-stained lymphatic vessel draining the tumor and the SLN was labeled with alcian blue. Metastases within the serially sectioned SLNs were assigned to the alcian blue-labeled side, to the opposite side of the virtually halved nodes, or both. Eight SLNs were negative for metastasis. Eleven SLNs had metastases only in the blue half only 4 cases had larger metastases in the nonblue half. Metastases are more likely to be located in the vicinity of the inflow junction of the identifiable lymphatic draining the tumor and the SLN. This should be considered when SLNs are examined, especially when they are halved for different studies.",
keywords = "Axillary sentinel node, Breast cancer, Histology, Lymphatic mapping, PCR, Polymerase chain reaction",
author = "G. Cserni",
year = "2000",
language = "English",
volume = "113",
pages = "351--354",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "3",

}

TY - JOUR

T1 - Mapping metastases in sentinel lymph nodes of breast cancer

AU - Cserni, G.

PY - 2000

Y1 - 2000

N2 - Localization of metastases within the sentinel lymph nodes (SLNs) of breast cancer has not been studied. Forty SLNs from 36 patients with operable primary breast cancers were identified by means of lymphatic mapping with patent blue dye. The junction between the patent blue-stained lymphatic vessel draining the tumor and the SLN was labeled with alcian blue. Metastases within the serially sectioned SLNs were assigned to the alcian blue-labeled side, to the opposite side of the virtually halved nodes, or both. Eight SLNs were negative for metastasis. Eleven SLNs had metastases only in the blue half only 4 cases had larger metastases in the nonblue half. Metastases are more likely to be located in the vicinity of the inflow junction of the identifiable lymphatic draining the tumor and the SLN. This should be considered when SLNs are examined, especially when they are halved for different studies.

AB - Localization of metastases within the sentinel lymph nodes (SLNs) of breast cancer has not been studied. Forty SLNs from 36 patients with operable primary breast cancers were identified by means of lymphatic mapping with patent blue dye. The junction between the patent blue-stained lymphatic vessel draining the tumor and the SLN was labeled with alcian blue. Metastases within the serially sectioned SLNs were assigned to the alcian blue-labeled side, to the opposite side of the virtually halved nodes, or both. Eight SLNs were negative for metastasis. Eleven SLNs had metastases only in the blue half only 4 cases had larger metastases in the nonblue half. Metastases are more likely to be located in the vicinity of the inflow junction of the identifiable lymphatic draining the tumor and the SLN. This should be considered when SLNs are examined, especially when they are halved for different studies.

KW - Axillary sentinel node

KW - Breast cancer

KW - Histology

KW - Lymphatic mapping

KW - PCR

KW - Polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0034005550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034005550&partnerID=8YFLogxK

M3 - Article

C2 - 10705814

AN - SCOPUS:0034005550

VL - 113

SP - 351

EP - 354

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 3

ER -